Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амген Инк., Байовитрум АбfiledCriticalАмген Инк.
Publication of UA86813C2publicationCriticalpatent/UA86813C2/en
The present invention relates to compounds with the formula (І), (II), (III) or (IV): (I) (II), (III), or (IV), wherein R, R, R, R, R, R, R, X and Z are as defined herein, and also to pharmaceutical compositions comprising the compounds, as well as methods of use of the compounds for treatment of disorders associated with human 11--hydroxysteroid dehydrogenase type 1 enzyme and for the preparation of a medicament which acts on the human 11--hydroxysteroid dehydrogenase type 1 enzyme.
UAA200613767A2004-05-242005-05-24Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
UA86813C2
(en)